Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
School of Law, The University of Texas, Austin, Texas 78705, USA. jrobertson@mail.law.utexas.edu
The clinical use of pharmacogenetic drugs will require that a sample of a patient's DNA be tested before a drug is prescribed. Although pharmacogenetic tests pose fewer risks than genetic tests for disease mutations, they might still reveal personal information that could be used adversely to a patient's interests. Informed consent and privacy of pharmacogenetic test results may be essential in most clinical uses of pharmacogenetic drugs.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on